Jerzy Gumulka Net Worth & Insider Trades

Jerzy Gumulka - Director, Cns Pharmaceuticals, Inc

As of September 25, 2023

What is Jerzy Gumulka's Net Worth?

The current estimated net worth of Cns Pharmaceuticals, Inc's Director, Jerzy Gumulka, is estimated to be about $2.01K . Jerzy Gumulka owns about 9,673 units of Cns Pharmaceuticals, Inc common stock. In the last 3 years at Cns Pharmaceuticals, Inc, Jerzy Gumulka has sold an estimated value of $0 worth.

What is Jerzy Gumulka's Past Insider Trading?

Jerzy Gumulka's largest purchase order was 7,173 units , worth over $5.31K on April 17, 2023. In total, Jerzy Gumulka has made about 5 transactions over 3 years of their time at Cns Pharmaceuticals, Inc. Jerzy Gumulka usually trades in April, with the busiest year in 2023. The most recent transaction was a purchase order of 2,500 units , worth over $4.25K on April 21, 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Jerzy Gumulka

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Jerzy Gumulka's' Mailing Address?

  • Mailing address is C/o Cns Pharmaceuticals, Inc. 2100 West Loop South Ste 900 Houston TX 77027 TX

What are Cns Pharmaceuticals, Inc's Past Insider Trades?

Cns Pharmaceuticals, Inc's most recent insider trade came on August 23, 2023 by Christopher Downs who bought 27,000 units worth $34.18K . In the last 3 years, insiders at Cns Pharmaceuticals, Inc have sold an estimated value of $133.11K and bought an estimated value of $399.35K worth of shares. Insider trading is most common in September, April and March, with the busiest year in 2023. The most active traders at the company are Christopher Downs, Chief Financial Officer,  John M Climaco, Chief Executive Officer,  and Jerzy Gumulka, Director .

CNS Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...